Patents

Dr. Rodriguez is a renowned specialist in neuroregeneration. His research has resulted in patent awards to him and his Mayo Clinic research collaborators, signaling that these discoveries may soon be used in patient treatment. Explore our patents:

Investigator Patent Title Patent Number Patent Date
Moses Rodriguez, M.D. and Jim Maher Ph.D. DNA Aptamers for Promoting Remyelination US No. 9,809,823 Nov. 7, 2017
Moses Rodriguez, M.D. Human IgG Antibodies, and Diagnostic and Therapeutic Uses Thereof Particularly in the Central Nervous System U.S. No. 9,260,612 B2 Feb. 16, 2016
Moses Rodriguez, M.D. Human IgM Antibodies with the Capability of Inducing Remyelination, and Diagnostic and Therapeutic Uses Thereof Particularly in the Central Nervous System HK Patent No. HK1154604 Feb 16, 2016
Moses Rodriguez, M.D. and Arthur E. Warrington Jr., Ph.D. Antibody-Induced Remyelination as a Treatment for Neonatal White Matter Injury U.S. No. 62/076,669 Nov. 7, 2014
Moses Rodriguez, M.D. Human Antibodies and Specific Binding Sequences Thereof for Use in Stroke and Ischemia or Ischemic Conditions U.S. No. 14/395,141 Oct. 17, 2014
Moses Rodriguez, M.D. Promotion of Central Nervous System Remyelination Using Human IgM Antibodies U.S. No. 7,807,166 Oct. 5, 2010
Isobel A. Scarisbrick, Ph.D. Method of Treating Multiple Sclerosis with Anti-K6 Antibody U.S. No. 7,754,216 July 13, 2010
Moses Rodriguez, M.D. Monoclonal Antibodies Which Promote Central Nervous System Remyelination Canadian No. 2,188,919 April 6, 2010
Moses Rodriguez, M.D. Promotion of Central Nervous System Remyelination using Human IgM Antibodies U.S. No. 7,473,423 Jan. 6, 2009
Moses Rodriguez, M.D. Human IgM Antibodies with the Capability of Inducing Remyelination, and Diagnostic and Therapeutic Uses Thereof, Particularly in the Central Nervous System Australian Patent No. 2000261978 Oct. 19, 2006
Moses Rodriguez, M.D. Monoclonal Antibodies which Promote Central Nervous System Demyelination Japanese Patent No. 3789472 2006
Moses Rodriguez, M.D. Monoclonal Antibodies which Promote Central Nervous System Remyelination European Patent No. 0801679 B1 March 9, 2005
Moses Rodriguez, M.D. Treatment of Central Nervous System Diseases by Antibodies Against Glatiramer Acetate No. 6,800,285 Oct. 5, 2004
Moses Rodriguez, M.D. Monoclonal Antibodies which Promote Central Nervous System Remyelination Korean (ROK) No. 406551 Oct. 28, 2003
Moses Rodriguez, M.D. Monoclonal Antibodies which Promote Central Nervous System Remyelination Mexican No. 204041 Sept. 3, 2001
Moses Rodriguez, M.D. Suppression of Demyelination by Interleukin-6 No. 5,863,529 Jan. 26, 1999
Moses Rodriguez, M.D. Method of Treating Autoimmune and/or Viral Induced Diseases that are Mediated by CD8 Phenotype T Cells No. 5,660,828 Aug. 26, 1997
Moses Rodriguez, M.D. Monoclonal Antibodies which Promote Central Nervous System Remyelination No. 5,591,629 Jan. 7, 1997